We are live on
!
Find out more
WP
Woodline Partners Portfolio holdings
AUM
$26.4B
1-Year Est. Return
44.85%
This Fund
S&P 500
This Quarter
Est. Return
+8.39%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
–
AUM
$7.35B
AUM Growth
-$124M
(-1.7%)
Cap. Flow
-$457M
Cap. Flow
% of AUM
-6.22%
Top 10 Holdings %
Top 10 Hldgs %
16.8%
Holding
945
New
203
Increased
182
Reduced
140
Closed
326
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amphenol
APH
|
+$135M |
| 2 |
Keysight
KEYS
|
+$120M |
| 3 |
Baxter International
BAX
|
+$102M |
| 4 |
RTX Corp
RTX
|
+$96.1M |
| 5 |
Revolution Medicines
RVMD
|
+$73.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TE Connectivity
TEL
|
+$173M |
| 2 |
Teradyne
TER
|
+$107M |
| 3 |
Booking.com
BKNG
|
+$95.2M |
| 4 |
Electronic Arts
EA
|
+$85.2M |
| 5 |
Thermo Fisher Scientific
TMO
|
+$77M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 35.2% |
| 2 | Technology | 26.7% |
| 3 | Industrials | 12.14% |
| 4 | Consumer Discretionary | 7.06% |
| 5 | Communication Services | 4.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Option Care Health
OPCH
$3.55B
| $20.3M | 0.28% |
+639,243
| New | +$19.2M |
|
|
EXAS
102
DELISTED
Exact Sciences
EXAS
| $20M | 0.27% |
295,323
+165,926
| +128% | +$10.7M |
|
|
CVII
103
DELISTED
Churchill Capital Corp VII Class A Common Stock
CVII
| $19.9M | 0.27% |
1,959,799
| – | – |
|
104
Paylocity
PCTY
$7.67B
| $19.7M | 0.27% |
98,994
+55,638
| +128% | +$10.9M |
|
105
Arcturus Therapeutics
ARCT
$177M
| $19.6M | 0.27% |
818,438
+66,107
| +9% | +$1.19M |
|
106
Intuit
INTU
$88.5B
| $19.5M | 0.27% |
43,837
+41,722
| +1,973% | +$17.1M |
|
107
Ferguson
FERG
$49.6B
| $19.3M | 0.26% |
+144,300
| New | +$20.1M |
|
108
Editas Medicine
EDIT
$425M
| $19.2M | 0.26% |
2,646,620
+567,872
| +27% | +$5.05M |
|
109
Ball Corp
BALL
$17B
| $18.9M | 0.26% |
+342,779
| New | +$19.1M |
|
110
Globant
GLOB
$1.65B
| $18.9M | 0.26% |
+115,131
| New | +$18.8M |
|
111
Amgen
AMGN
$210B
| $18.8M | 0.26% |
77,887
+2,137
| +3% | +$525K |
|
|
ONC
112
BeOne Medicines Ltd
ONC
$33.5B
| $18.7M | 0.25% |
+86,545
| New | +$20.8M |
|
|
MAXR
113
DELISTED
Maxar Technologies Inc. Common Stock
MAXR
| $18.5M | 0.25% |
361,800
+190,285
| +111% | +$9.74M |
|
114
Nutanix
NTNX
$16.6B
| $18.4M | 0.25% |
708,686
+222,821
| +46% | +$6.03M |
|
115
Microsoft
MSFT
$3.66T
| $18.3M | 0.25% |
63,347
-260,012
| -80% | -$66.3M |
|
116
Bristol-Myers Squibb
BMY
$135B
| $18.1M | 0.25% |
261,613
+2,943
| +1% | +$208K |
|
117
Cardinal Health
CAH
$54.7B
| $18M | 0.25% |
238,829
+114,182
| +92% | +$8.61M |
|
|
TXNM
118
TXNM Energy Inc
TXNM
$5.94B
| $18M | 0.25% |
369,895
-122,185
| -25% | -$6M |
|
|
APEN
119
DELISTED
Apollo Endosurgery, Inc.
APEN
| $17.9M | 0.24% |
1,809,001
+1,046,201
| +137% | +$10.4M |
|
120
CACI
CACI
$11.6B
| $17.8M | 0.24% |
60,040
-2,081
| -3% | -$613K |
|
121
Edwards Lifesciences
EW
$51.6B
| $17.3M | 0.24% |
209,249
+160,931
| +333% | +$12.6M |
|
|
AVDL
122
DELISTED
Avadel Pharmaceuticals
AVDL
| $17.2M | 0.23% |
1,879,343
+1,266,202
| +207% | +$10.4M |
|
123
Bentley Systems
BSY
$11B
| $17M | 0.23% |
+395,311
| New | +$15.7M |
|
124
lululemon athletica
LULU
$14B
| $16.6M | 0.23% |
45,689
+1,450
| +3% | +$455K |
|
125
Synaptics
SYNA
$4.16B
| $16.6M | 0.23% |
149,311
-9,338
| -6% | -$1.08M |
|
Similar funds
PAM
TCIIS
UIM
VAI
Woodline Partners's Q1 2023 Portfolio in Review
As of Q1 2023, Woodline Partners held 945 positions worth $7.35B, down 1.7% from $7.47B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Woodline Partners withdrew a net $457M in Q1 2023, closing 326 positions and reducing 140 holdings. Its most notable exit was Electronic Arts, an estimated $85.2M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 35% of assets, up from 33% a quarter earlier, followed by Technology and Industrials.
Against the trend, Woodline Partners opened a new position in Amphenol worth $139M.
- Woodline Partners's largest Q1 2023 buy was Amphenol: 3,410,252 shares worth $139M.
- Woodline Partners added most to Baxter International in Q1 2023, an estimated $102M increase.
- Woodline Partners's biggest Q1 2023 reduction was TE Connectivity, cutting an estimated $173M.
- Woodline Partners fully exited Electronic Arts in Q1 2023, selling an estimated $85.2M.
- Woodline Partners's ten largest holdings make up 17% of its $7.35B portfolio in Q1 2023.
- Woodline Partners opened 203 new positions and closed 326 in Q1 2023.
- Woodline Partners's portfolio value fell 1.7% quarter-over-quarter to $7.35B.
Based on Woodline Partners's 13F filing for Q1 2023, filed 15 May 2023.